TARA Company Profile and Key Details
Protara Therapeutics, Inc.
TARA Stock Price Chart
Stock Price Today
Protara Therapeutics, Inc. (TARA) stock surged +3.44%, trading at $5.11 on NASDAQ, up from the previous close of $4.94. The stock opened at $5.03, fluctuating between $4.98 and $5.26 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Company Information
| Employees | 26 |
| Beta | 1.79 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Protara Therapeutics, Inc. (NASDAQ: TARA) stock price is $5.11 in the last trading session. During the trading session, TARA stock reached the peak price of $5.26 while $4.98 was the lowest point it dropped to. The percentage change in TARA stock occurred in the recent session was 3.44% while the dollar amount for the price change in TARA stock was $0.17.
The NASDAQ listed TARA is part of Biotechnology industry that operates in the broader Healthcare sector. Protara Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.
Co-Founder, Senior Vice President & Chief Scientific Operations Officer
Ms. Mary J. Grendell
Gen. Counsel & Corporation Sec.
Dr. Jathin Bandari M.D.
Chief Medical Officer
Ms. Kristine Rosse
Senior Vice President & Chief People Officer
Mr. Jesse Shefferman
Co-Founder, Chief Executive Officer, Pres & Director
Ms. Hannah Fry
Vice President, Principal Accounting Officer & Controller
Ms. Justine O'Malley
Senior Vice President of Investor Relations & Corporation Affairs
TARA's closing price is 220.38% higher than its 52-week low of $1.60 where as its distance from 52-week high of $10.48 is -51.24%.
Number of TARA employees currently stands at 26.
Official Website of TARA is: https://www.protaratx.com
TARA could be contacted at phone 646 844 0337 and can also be accessed through its website. TARA operates from 345 Park Avenue South, New York, NY 10010, United States.
TARA stock volume for the day was 215.97K shares. The average number of TARA shares traded daily for last 3 months was 2.45M.
The market value of TARA currently stands at $175.37M with its latest stock price at $5.11 and 34.32M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com